Literature DB >> 3085090

Influence of delayed immune reactions on human epidermal keratinocytes.

G Kaplan, M D Witmer, I Nath, R M Steinman, S Laal, H K Prasad, E N Sarno, U Elvers, Z A Cohn.   

Abstract

The epidermal changes that occur in human cutaneous immune responses have been investigated in the tuberculin reaction and in the lesions of tuberculoid and lepromatous leprosy and cutaneous leishmaniasis. In each situation, there was a dermal accumulation of monocytes and T cells, and the epidermis exhibited thickening. In the tuberculin response, the thickness of the epidermis sometimes doubled in 48-72 hr, and this was attributed to increases in both size and number of keratinocytes. In addition, the phenotype of the keratinocytes changed from Ia- to Ia+. Similar changes in keratinocyte Ia-antigen expression occurred in the epidermis overlying untreated tuberculoid leprosy and cutaneous leishmaniasis lesions, but not in lepromatous leprosy. We suggest that one or more epidermal growth factors may be generated in the course of a delayed immune reaction in the dermis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085090      PMCID: PMC323537          DOI: 10.1073/pnas.83.10.3469

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma.

Authors:  J G Rheinwald; H Green
Journal:  Cell       Date:  1975-11       Impact factor: 41.582

Review 2.  Immunological aspects of leprosy--present status.

Authors:  T Godal
Journal:  Prog Allergy       Date:  1978

3.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

Review 4.  The keratinocyte as differentiated cell type.

Authors:  H Green
Journal:  Harvey Lect       Date:  1980

5.  In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.

Authors:  A Scheynius; L Klareskog; U Forsum
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

6.  The stimulation of epidermal proliferation by a specific protein (EGF).

Authors:  S Cohen
Journal:  Dev Biol       Date:  1965-12       Impact factor: 3.582

7.  Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).

Authors:  T A Luger; B M Stadler; S I Katz; J J Oppenheim
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

8.  Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes.

Authors:  J Auböck; D Niederwieser; N Romani; P Fritsch; C Huber
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

9.  Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells.

Authors:  P S Steeg; R N Moore; J J Oppenheim
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages.

Authors:  R M Steinman; N Nogueira; M D Witmer; J D Tydings; I S Mellman
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  29 in total

1.  Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.

Authors:  Z Bata-Csorgo; C Hammerberg; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

2.  Immunohistological evidence of lymphokine production and lymphocyte activation antigens in tuberculin reactions.

Authors:  M A Fullmer; J Y Shen; R L Modlin; T H Rea
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

3.  Relationship between macrophage infiltration and epidermopoiesis in delayed-type hypersensitivity.

Authors:  T Tanaka; S Imamura; M Takigawa
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

Review 4.  Immunopathology of leprosy granulomas.

Authors:  R L Modlin; T H Rea
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.

Authors:  G Kaplan; G Sheftel; C K Job; N K Mathur; I Nath; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Epidermis and lymphocyte interactions during a tuberculin skin reaction. I. Increased ETAF/IL-1 like activity, expression of tissue antigens and mixed skin lymphocyte reactivity.

Authors:  C G Larsen; T Ternowitz; F G Larsen; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

7.  Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

8.  Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.

Authors:  G Kaplan; A Nusrat; E N Sarno; C K Job; J McElrath; J A Porto; C F Nathan; Z A Cohn
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

9.  Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

Authors:  R M Grossman; J Krueger; D Yourish; A Granelli-Piperno; D P Murphy; L T May; T S Kupper; P B Sehgal; A B Gottlieb
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.

Authors:  G Kaplan; E P Sampaio; G P Walsh; R A Burkhardt; T T Fajardo; L S Guido; A de Miranda Machado; R V Cellona; R M Abalos; E N Sarno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.